CAH
Cardinal Health, Inc. · NYSE · Healthcare · USD · 10-K for 2026, filed 2026-08-11
Figures on this page computed 2026-11-08 12:24 UTC
Last close
271.72USD
Market data, 2026-11-06
Except where said otherwise: 10-K for 2026, filed 2026-08-11
37.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
- computed
- 10-K for 2026, filed 2026-08-11
85.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
0.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
1.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
- 10-K for 2026, filed 2026-08-11
- 10-K for 2026, filed 2026-08-11
0.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2026, filed 2026-08-11
Margins is the furthest below its sector's middle: 0.36 against 0.36 on the market's range.
Against its rival
lens 4 of 9Measure by measure
behind on 1 of 5- Profit on each unit of sales0.7%0.5%Ahead
Higher is better here.
- Return on the capital it uses85.6%28.2%Ahead
Higher is better here.
- Sales growth over five years9.4%11.1%Behind
Higher is better here.
- Debt against equityn/a6.19n/a
Lower is better here.
- Gross margin3.8%3.6%Ahead
Higher is better here.
- Price against earnings37.4x41.6xAhead
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Cencora, Inc., CAH is behind on 1 of 5 measures.
Against Cencora, Inc., CAH is behind on 1 of 5 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2026, filed 2026-08-11
Profit on each unit of sales0.7%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
Return on the capital it uses85.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
Sales growth over five years9.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
Debt against equityn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
Gross margin3.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD
Price against earnings37.4x
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000721371-26-000038
- Reported in
- USD